Alentis

View On IC.GC.CA

REGISTERED

on 17 Feb 2025

TM5 Status

LIVE/APPLICATION/ Published for Opposition

Your application has been published for opposition.

Last Applicant/ Owned by

Alentis Therapeutics AG

Hegenheimermattweg 167ACH-4123 Allschwil

Serial Number

2183565 filed on 7^th Feb 2022

Registration Number

TMA1291247 registered on 17^th Feb 2025

Registration expiry Date

7^th Feb 2032

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

K1P5Y6

Alentis

Trademark usage description

pharmaceutical products for the treatment of cancer, autoimmune diseases and organ fibrosis, all of the aforementioned products for not ophthalmologic Read More

Vienna Information

26 . 3 . 1

One triangleUn triangle

26 . 3 . 23

Lines or bands forming an angle -- Note: Including chevrons and arrowheads formed by lines or bands.Lignes ou bandes formant un angle -- Note: Y compris les chevrons et les pointes de flèches formées par des lignes ou des bandes.

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

27 . 1 . 1

Letters or numerals forming geometrical figures, written or typographical matter in perspectiveLettres ou chiffres formant des figures géométriques, inscriptions en perspective

27 . 1 . 5

Letters or numerals forming a triangle (surface or periphery)Lettres ou chiffres formant un triangle (surface ou pourtour)

Classification Information

Class [005]
Pharmaceutical products for the treatment of cancer, autoimmune diseases and organ fibrosis, all of the aforementioned products for not ophthalmological use; chemical preparations for medical and veterinary use, namely for the treatment of cancer, autoimmune diseases and organ fibrosis, all of the aforementioned products for not ophthalmological use; biological preparations for medical and therapeutic use, namely for the treatment of cancer, autoimmune diseases and organ fibrosis, all the aforementioned products not for ophthalmological use; biopharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer.

Classification kind code

Class [042]
Scientific and medical research and development in the fields of fibrosis, autoimmune diseases and cancer; biotechnology research services in the fields of fibrosis, autoimmune diseases and cancer; provision of scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancer diseases; providing scientific advice and information in the pharmaceutical and biomedical field.

Classification kind code

Class [044]
Medical analysis services for the diagnosis of cancer; RNA or DNA analysis for cancer prognosis and diagnosis; provision of information in the field of prevention, screening, diagnosis and treatment of cancers; providing pharmaceutical and medication advice and information; medical tests.

Classification kind code

Mark Details

Serial Number

2183565

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 28^th Aug 2023	Search Recorded
Submitted for opposition 20 on 28^th Aug 2023	Examiner's First Report
Submitted for opposition 223 on 28^th Aug 2023	Total Provisional Refusal
Submitted for opposition 256 on 6^th Mar 2023	Notification of Possible Opposition Sent
Submitted for opposition 236 on 4^th Jul 2022	Partial Withdrawal - Madrid Protocol
Submitted for opposition 257 on 5^th May 2022	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 5^th May 2022	Formalized
Submitted for opposition 1 on 5^th May 2022	Created
Submitted for opposition 228 on 7^th Feb 2022	International Registration
Submitted for opposition 30 on 7^th Feb 2022	Filed